We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00739258
First Posted: August 21, 2008
Last Update Posted: January 23, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Centers for Disease Control and Prevention
Information provided by (Responsible Party):
Kaohsiung Medical University Chung-Ho Memorial Hospital
August 19, 2008
August 21, 2008
January 23, 2012
April 2008
December 2010   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00739258 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison
Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison and Set up the Notional Halfway Home in Union Area of Medical Facility
It is difficult to detect the intestinal protozoal infections among the HIV-infected persons or travelers diarrhea by using the traditional microscopy or staining methods. The purpose of this study aimed at finding out the appropriate diagnostic methods and the infection rate of the intestinal protozoa, including the Entamoeba, Cryptosporidium and Giardia among the HIV-infected persons by using the antigen detection method and biological method. The investigators also tried to analyze the associated HIV infection status and sexual transmitted diseases (STD) including Gonorrhea, Chlamydial trachomatis, Syphilis, Genital warts and Herpes simplex virus in this study. The study will collect the blood, urine and stool samples from 200 intravenous drug user (IDU) with HIV-infected in the prisons, 400 intravenous drug user (IDU) without HIV infected and 100 intravenous drug user (IDU) with HIV infected receiving methadone maintenance treatment.
Not Provided
Observational
Observational Model: Cohort
Not Provided
Not Provided
Non-Probability Sample
The samples are obtained from Kaohsiung prison, Kaohsiung women's prison, Pingtung prison and the Kaohsiung Medical University Chung-Ho Memorial Hospital in Kaohsiung, Taiwan.
HIV Infections
Not Provided
  • HIDU
    intravenous drug user (IDU) with HIV infected
  • IDU
    intravenous drug user (IDU) without HIV
  • MH
    persons receiving methadone maintenance treatment
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
700
December 2010
December 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinical diagnosis of HIV
  • Receiving Methadone Maintenance Treatment
  • intravenous drug user (IDU)
Sexes Eligible for Study: All
Child, Adult, Senior
Yes
Contact information is only displayed when the study is recruiting subjects
Taiwan
 
 
NCT00739258
KMUH-IRB-970077
No
Not Provided
Not Provided
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital
Centers for Disease Control and Prevention
Not Provided
Kaohsiung Medical University Chung-Ho Memorial Hospital
December 2011